Trials that use: Risk ratio / relative risk
New to this method? Read the tutorial →
6,204 results
- Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Concurrent Cisplatin Chemotherapy for Locally Advanced or Metastatic Malignant Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy to Treat Musculoskeletal Tumors: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy to Treat Musculoskeletal Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00186992).
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RADICALIndependent statistical analysis of Repeated Amiodarone Dosing In Cardiac surgicaL Procedures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05004077).
- Radiographic and Clinical Outcomes Following Unilateral or Bilateral Posterior Fixation in MI-TLIF: Complete Statistical AnalysisIndependent statistical analysis of Radiographic and Clinical Outcomes Following Unilateral or Bilateral Posterior Fixation in MI-TLIF: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Radiosurgery for Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Radiosurgery for Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00456612).
- Radiotherapy for Solid Tumor Spine Metastases: Complete Statistical AnalysisIndependent statistical analysis of Radiotherapy for Solid Tumor Spine Metastases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01752036).
- RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers: Complete Statistical AnalysisIndependent statistical analysis of RADVAX: A Stratified Phase I Trial of Pembrolizumab With Hypofractionated Radiotherapy in Patients With Advanced and Metastatic Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals: Complete Statistical AnalysisIndependent statistical analysis of Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01293123).
- Ramipril for the Treatment of Oligospermia: Complete Statistical AnalysisIndependent statistical analysis of Ramipril for the Treatment of Oligospermia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01856361).
- Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion:…
- Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: Complete Statistical AnalysisIndependent statistical analysis of Randomized Controlled Trial of Tranexamic Acid in Total Knee Arthroplasty: Intravenous vs. Topical: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma: Complete Statistical AnalysisIndependent statistical analysis of Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC): Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size…
- Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02203695).
- Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized Trial Comparing Irrisept to Saline Irrigation for Infection Prevention: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial Comparing Irrisept to Saline Irrigation for Infection Prevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05402995).
- Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Alternative HPV Vaccination Schedules in Males in a University Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: Complete Statistical AnalysisIndependent statistical analysis of RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00126672).
- RAPIDIndependent statistical analysis of Reducing Adenoviral Patient Infected Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02472223).
- RAPID KORIndependent statistical analysis of Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Rapid MRI for Acute Pediatric Head Trauma: Complete Statistical AnalysisIndependent statistical analysis of Rapid MRI for Acute Pediatric Head Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03291964).
- Rapid Non-Invasive Brain Stimulation for OCD (oTMS): Complete Statistical AnalysisIndependent statistical analysis of Rapid Non-Invasive Brain Stimulation for OCD (oTMS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03404609).
- RAPIDAIndependent statistical analysis of Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RAS and Coagulopathy in COVID19: Complete Statistical AnalysisIndependent statistical analysis of RAS and Coagulopathy in COVID19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04419610).
- RAS-HIVIndependent statistical analysis of Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02606279).
- RasbAKIIndependent statistical analysis of Lowering Serum Uric Acid to Prevent Acute Kidney Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00756964).
- Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: Complete Statistical AnalysisIndependent statistical analysis of Rasburicase in Patients at High Risk for Tumor Lysis Syndrome (TLS) During Cycle-2: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Rasburicase in Patients at Risk for Tumor Lysis Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Rasburicase in Patients at Risk for Tumor Lysis Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00628628).
- Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: Complete Statistical AnalysisIndependent statistical analysis of Rate of Complete Symptom Relief, Prevention of Symptom Relapse: Grades A and B Esophagitis of Esomeprazole Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RATE-RAIndependent statistical analysis of A Study on The Safety of Administering Rituximab at A More Rapid Rate in Patients With Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: Complete Statistical AnalysisIndependent statistical analysis of RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- RCTTMIndependent statistical analysis of Clinical Trial Tobacco Marijuana: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02277665).
- RDEBIndependent statistical analysis of A Pilot Study to Evaluate a Temporary Skin Substitute (Spincare® Matrix) for Wound Healing in RDEB Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RE-CHUTIndependent statistical analysis of Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed): primary endpoint results, effect estimate with confidence interval, sample-size…
- RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: Complete Statistical AnalysisIndependent statistical analysis of Re-differentiation of Radioiodine-Refractory BRAF V600E-mutant Papillary Thyroid Carcinoma With GSK2118436: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01534897).
- Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: Complete Statistical AnalysisIndependent statistical analysis of Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00675103).
- Re-expression of ER in Triple Negative Breast Cancers: Complete Statistical AnalysisIndependent statistical analysis of Re-expression of ER in Triple Negative Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01194908).
- Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size…